Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.

NCT04877496 · clinicaltrials.gov ↗

UNKNOWN

Status

425

Enrollment

OTHER

Sponsor class

Conditions

COVID19 Vaccination
Rituximab
Immunosuppression

Interventions

DRUG: History of exposure to anti-CD20 treatment since 01/01/2010
BIOLOGICAL: Completion of COVID19 vaccine at least 4 weeks ago

Sponsor

Insel Gruppe AG, University Hospital Bern